Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
651
-
Total shares
-
79.5M
-
Shares change
-
-180K
-
Total reported value, excl. options
-
$17.3B
-
Value change
-
-$17.9M
-
Put/Call ratio
-
0.85
-
Number of buys
-
265
-
Number of sells
-
-300
-
Price
-
$217.94
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2018
663 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2018.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 651 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.5M shares
of 80.8M outstanding shares and own 98.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.89M shares), BlackRock Inc. (6.28M shares), Fundsmith Equity Fund, L.P. (4.43M shares), Fundsmith LLP (4.43M shares), BAMCO INC /NY/ (4.37M shares), STATE STREET CORP (3.43M shares), RENAISSANCE TECHNOLOGIES LLC (2.17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.11M shares), AMERIPRISE FINANCIAL INC (1.63M shares), and BLAIR WILLIAM & CO/IL (1.57M shares).
This table shows the top 651 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.